- Filed
- Apr 25, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 12, 2024 | 24.61M sh |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $61.26M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $61.4M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $261.72M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $209.62M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $512.65M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $472.7M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $390.45M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $329.07M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $2.16B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $2.13B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $168.48M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $202.82M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 23.43M sh |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $14.76M |
| Capex | Q1 2024 · Mar 31, 2023 | $8.27M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $35.24M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $1.61B |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $1.64B |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.09 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.09 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $95.47M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.03M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.35M |
| Revenue | Q1 2024 · Mar 31, 2023 | $256.61M |